Content reuse is the practice of creating one piece of content and then using that piece of content everywhere you need it. A reused piece of content is created, finalized, translated, managed, stored, and retired one, and only one, time.
As you prepare your content for generative AI, it’s important that you understand the two types of output content: persistent and transitory.
The following guidelines will help you build your skills and deepen your understanding of why structure requires us to change how we write.
To automate content development, pharmaceutical companies must move to structured content authoring.
In pharma, some digital marketing teams have embraced multi-channel publishing as a way to meet regulatory requirements.
Because labeling is global and requires localization, pharma companies gain even more benefit from content reuse.
Legacy tools and processes no longer support the business objectives for pharma. The only way to meet the growing demands for more content, faster, is to adopt a structured content ecosystem.
There is no such thing as a perfect structure because it is going to change over time. With new products and services should come new content types. And new content types often require new structures.
There are many reasons why a component structured content management (SCM) system is superior to using a Microsoft Word document for managing your Company Core Data Sheet (CDS or CCDS). We touched upon some of the reasons in our previous blog post, The CDS is Dead! Long Live the CDS!
We talk a lot about the goal of enterprise content strategy for pharma: to help speed up the process of making safe, effective medicines.